Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
828,585
-
Shares change
-
-3,034
-
Total reported value, excl. options
-
$66,678,384
-
Value change
-
-$232,033
-
Put/Call ratio
-
270%
-
Number of buys
-
31
-
Number of sells
-
-25
-
Price
-
$80.45
Significant Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q2 2021
95 filings reported holding PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS as of Q2 2021.
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 828,585 shares
.
Largest 10 shareholders include Peak Asset Management, LLC (118,643 shares), BANK OF AMERICA CORP /DE/ (76,055 shares), LPL Financial LLC (60,287 shares), UBS Group AG (50,716 shares), GOLDMAN SACHS GROUP INC (50,133 shares), Federation des caisses Desjardins du Quebec (38,763 shares), MORGAN STANLEY (38,414 shares), CREDIT SUISSE AG/ (34,934 shares), WELLS FARGO & COMPANY/MN (23,713 shares), and COMMONWEALTH EQUITY SERVICES, LLC (23,233 shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.